Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-05-07Clinical Trial Update: Repeat-Dose Study of Bavituximab in Patients With Chronic Hepatitis C [Phase 1]
A phase 1 repeat-dose study of the antibody bavituximab in patients with chronic hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2008-05-07Clinical Trial Update: Study of Bavituximab in Patients With Chronic Hepatitis C Virus Infection [Phase 1]
Phase 1 clinical trial update showing completion for Bavituximab in patients with chronic hepatitis C virus infection.
-
CLINICAL_TRIALS trial_result · 2008-04-17Clinical Trial Update: Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Therapy [Phase 4]
Phase 4 study evaluating high-dose interferon alfacon-1 (CIFN) plus ribavirin in Hepatitis C genotype 1 patients who did not respond to prio…
-
CLINICAL_TRIALS trial_result · 2008-04-14Clinical Trial Update: Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults [Phase 1]
Phase 1 safety study of the investigational hepatitis C drug HCV-796 in subjects with hepatic insufficiency and in healthy adults has comple…
-
CLINICAL_TRIALS trial_result · 2008-04-10Clinical Trial Update: Study of AVI-4065 in Healthy Volunteers and Chronic Active HCV Patients [Phase 1, Phase 2]
The Phase 1/2 clinical trial of AVI-4065 in healthy volunteers and patients with chronic active Hepatitis C was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-04-08Clinical Trial Update: A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C [Phase 2]
Phase 2 study evaluating the safety, antiviral effect, and pharmacokinetics of Celgosivir in combination with peginterferon alfa-2b and riba…
-
CLINICAL_TRIALS trial_result · 2008-04-07Clinical Trial Update: Multicenter Study Evaluating 12 Versus 24 Weeks Therapy With Peginterferon and Ribavirin for Hepatitis C Virus (HCV) Genotype 2 or 3 [Phase 4]
A multicenter Phase 4 study comparing 12 weeks versus 24 weeks of pegylated interferon plus ribavirin in hepatitis C with genotypes 2 or 3 h…
-
CLINICAL_TRIALS trial_result · 2008-03-28Clinical Trial Update: HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a MMT Group. [Phase 3]
The HEPMET-1 Phase 3 trial evaluated feasibility, mental side effects, and efficacy of Hepatitis C treatment in patients on methadone mainte…
-
CLINICAL_TRIALS trial_result · 2008-03-07Clinical Trial Update: Safety Study of Low Dose Interleukin 2 (IL-2) Plus PEG-IFN/RBV In Chronic Hepatitis C Virus Genotype I [Phase 1]
A Phase 1 safety study of low-dose interleukin-2 combined with PEG-IFN/RBV for chronic hepatitis C genotype I was terminated.
-
CLINICAL_TRIALS trial_result · 2008-03-06Clinical Trial Update: A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients [Phase 4]
A Phase 4 randomized trial compares 24-week versus 48-week courses of peginterferon plus ribavirin in genotype-1 chronic hepatitis C patient…
-
CLINICAL_TRIALS trial_result · 2008-03-06Clinical Trial Update: Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal Disease [Phase 4]
Phase 4 trial evaluating interferon treatment for chronic hepatitis C in patients with end-stage renal disease has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-06Clinical Trial Update: Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Biochemical and Duplex Doppler Indices
A completed clinical trial evaluating the ability to predict hepatic fibrosis in chronic hepatitis C patients using biochemical measurements…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Gamma Interferon Therapy for Chronic Hepatitis C [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating gamma interferon therapy for chronic hepatitis C.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV
The clinical trial update reports results from a completed NIH study evaluating nucleic acid amplification testing for detecting Hepatitis C…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Combination Drug Therapy for Patients With Hepatitis C [Phase 3]
A Phase 3 clinical trial update on a combination drug therapy for chronic hepatitis C with liver fibrosis, with the study status shown as co…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin [Phase 2]
A Phase 2 trial update examining whether HAART affects response to hepatitis C therapy with peginterferon alpha-2b and ribavirin in HIV/Hepa…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: History of Hepatitis C in Volunteer Blood Donors
A completed NIDDK-sponsored clinical trial examining the history of Hepatitis C in volunteer blood donors.
-
CLINICAL_TRIALS trial_result · 2008-02-26Clinical Trial Update: Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4 [Phase 4]
A Phase 4 clinical trial evaluating pegylated interferon and ribavirin therapy for chronic hepatitis C genotype 4 has completed.
-
CLINICAL_TRIALS trial_result · 2008-02-20Clinical Trial Update: Phase I Trial of Silymarin for Chronic Liver Diseases [Phase 1]
This update reports the completion of a Phase I study of silymarin for chronic liver diseases, including hepatitis C and non-alcoholic fatty…
-
CLINICAL_TRIALS trial_result · 2008-02-12Clinical Trial Update: Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 and/or 4 [Phase 4]
Phase 4 trial evaluating extending treatment to 24 weeks in HIV-Hepatitis C co-infected patients (genotypes 1 and/or 4), with outcomes on ef…
-
CLINICAL_TRIALS trial_result · 2008-02-08Clinical Trial Update: Efficacy of Prazosin Versus Placebo Associated With Peg-Interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis [Phase 2]
Phase 2 trial evaluating whether adding prazosin to peg-interferon alfa-2b and ribavirin improves efficacy in chronic hepatitis C with genot…
-
CLINICAL_TRIALS trial_result · 2008-02-08Clinical Trial Update: Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease
A completed clinical trial evaluating a T cell phenotype activation pathway in alcoholic liver disease. The study also lists chronic hepatit…
-
CLINICAL_TRIALS trial_result · 2008-02-08Clinical Trial Update: Efficacy of Pegylated Interferon Alone in Egyptian Patients With Acute Hepatitis C (ANRS 1213) [Phase 3]
Phase 3 trial assessing the efficacy of Pegylated Interferon alone in adults with acute hepatitis C in Egypt has completed.
-
CLINICAL_TRIALS trial_result · 2008-01-21Clinical Trial Update: An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection [Phase 2]
A Phase 2 extension study evaluating the safety and efficacy of celgosivir with peginterferon alfa-2b, with or without ribavirin, in patient…
-
CLINICAL_TRIALS trial_result · 2008-01-15Clinical Trial Update: Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin [Phase 3]
A Phase 3 clinical trial evaluating thymosin in combination with pegylated interferon for non-cirrhotic hepatitis C patients who did not res…